Global Infectious Testing Market, By Product and Service (Assays, Kits and Reagents, Instruments and Services and Software), Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and Next-Generation Sequencing (NGS), DNA Microarray and Other Technologies), Disease Type (Hepatitis, Human Immunodeficiency Virus (HIV), Chlamydia Trachomatis Genital Infection and Gonorrhoea (CT/NG), Hospital-Acquired Infections (HAIS), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza and Other Infectious Disease), End User (Hospital/ Clinical Laboratories, Reference Laboratories, Physician Offices, Academic/ Research Institutes and Other End Users), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Global Infectious Testing Market
Data Bridge Market Research analyses that the infectious testing market will exhibit a CAGR of around 4.82% for the forecast period of 2021-2028. Rising prevalence of a wide variety of infectious diseases, rising research and development proficiencies and increasing public and private expenditure for the development of healthcare infrastructure especially in emerging economies are the major factors attributable to the growth of infectious testing market.
From the name itself, it is clear that infectious testing is used for the testing of infectious diseases in humans that is generally caused by either bacteria or virus. The infectious diseases are transmissible diseases and therefore it is important to get them diagnosed and treated.
Upsurge in the prevalence of bacterial diseases and viral infections are one of the major factors inducing growth in the infectious testing market value. Rising adoption of advanced healthcare technologies against communicable infectious diseases will further generate lucrative and remunerative growth opportunities for the infectious testing market. Growth in the number of diagnostics tests, increased focus of the manufacturers on advanced diagnostics equipment and increasing personal disposable income will also act as an important infectious testing market growth determinant.
However, rising costs associated with healthcare services will create hindrances for the infectious testing market. Availability of alternative treatments such as molecular techniques and stringent regulatory approval procedure for infectious diagnostic devices will further challenge the infectious testing market growth rate. Lack of a favourable and inadequate reimbursement scenario in the developing and under developing economies will also dampen the infectious testing market growth rate.
This infectious testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on infectious testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Infectious Testing Market Scope and Market Size
The infectious testing market is segmented on the basis of product and service, technology, disease type and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
By product and service, the global infectious testing market is segmented into assays, kits and reagents, instruments and services and software.
- On the basis of technology, the infectious testing market is segmented into immunodiagnostics, clinical microbiology, polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), DNA sequencing and next-generation sequencing (NGS), DNA microarray and other technologies.
- On the basis of disease type, the infectious testing market is segmented into hepatitis, human immunodeficiency virus (HIV), chlamydia trachomatis genital infection and gonorrhoea (CT/NG), hospital-acquired infections (HAIS), human papillomavirus (HPV), tuberculosis (TB), influenza and other infectious disease.
- On the basis of end user, the infectious testing market is segmented into hospital/ clinical laboratories, reference laboratories, physician offices, academic/ research institutes and other end users.
Global Infectious Testing Market Country Level Analysis
Global infectious testing market is analysed and market size insights and trends are provided by country, product and service, technology, disease type and end user as referenced above.
The countries covered in the infectious testing market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the infectious testing market owing to the rising prevalence of presence of major healthcare providers and favourable reimbursement scenario in this region. Asia-Pacific on the other hand is projected to undergo the highest growth rate during the forecast period owing to the rapid healthcare infrastructure development and rising prevalence of infectious diseases.
The country section of the infectious testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The infectious testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for infectious testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the infectious testing market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Infectious Testing Market Share Analysis
The infectious testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to infectious testing market.
The major players covered in the infectious testing market report are F. Hoffmann-La Roche Ltd, Abbott, bioMérieux SA, BD, Siemens Healthcare Private Limited, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc, Sysmex Corporation, Beckman Coulter, Inc., Danaher, Chembio Diagnostics, Inc., Cepheid, Trinity Biotech, Sekisui Diagnostics, Quidel Corporation, MedMira Inc., Calypte, Quest Diagnostics Incorporated, Bayer AG and Aperiomics among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-